xIPOmeter
Generate Biomedicines
Generate Biomedicines utiliza el aprendizaje automático para descubrir y crear nuevos fármacos biológicos para una amplia gama de enfermedades. La plataforma de esta empresa acelera el proceso de descubrimiento de fármacos, reduciendo el tiempo y el coste asociados a los métodos tradicionales. Generate Biomedicines está a la vanguardia de la fusión de la inteligencia artificial con el desarrollo de fármacos.
Gráfico NewsHeat
- Semana
- Mes
- Año
- Noticias de prensa
- Noticias corporativas
Los datos del gráfico anterior se basan en datos derivados de nuestro modelo de cálculo XP patentado y pueden modificarse, ajustarse y actualizarse sin previo aviso.
Valoración de empresas
- Valoración
- Precio de las acciones
- Financiación acumulada
Los datos de los cuadros y gráficos se basan en datos de fuentes públicas y, aunque hacemos todo lo posible por recopilarlos, es posible que no coincidan con los datos reales del emisor.
*** - Para ver los datos, conéctese a su cuenta o cree una nueva.
Calculadora de valoración de empresas
Para calcular, especifique uno de los parámetros
Noticias relacionadas con Generate Biomedicines8
Generate BiomedicinesGenerate:Biomedicines Expands Board of Directors with the ...
D., and Nancy Simonian, M.D., to its Board of Directors. Dr. Vessey's expertise in early-stage drug discovery and evolving bioplatforms, combined with Dr....
https://www.morningstar.com/news/business-wire/20240613510719/generatebiomedicines-expands-board-of-directors-with-the-appointment-of-rupert-vessey-md-phd-and-nancy-simonian-mdGenerate BiomedicinesGenerate:Biomedicines Expands Board of Directors with the ...
SOMERVILLE, Mass., June 13, 2024--Generate:Biomedicines today announced the appointment of Rupert Vessey, M.D., Ph.D., and Nancy Simonian, M.D., ...
https://finance.yahoo.com/news/generate-biomedicines-expands-board-directors-100000245.htmlGenerate BiomedicinesGenerate:Biomedicines Expands C-suite with Chief Corporate ...
Generate:Biomedicines today announces two key appointments, welcoming Kimberly (Kym) White as the new Chief Corporate Affairs Officer and announcing the ...
https://www.morningstar.com/news/business-wire/20240430610929/generatebiomedicines-expands-c-suite-with-chief-corporate-affairs-officer-and-chief-technical-operations-officerGenerate BiomedicinesGenerate:Biomedicines Expands C-suite with Chief Corporate ...
SOMERVILLE, Mass., April 30, 2024--Generate:Biomedicines today announces two key appointments, welcoming Kimberly (Kym) White as the new Chief Corporate ...
https://finance.yahoo.com/news/generate-biomedicines-expands-c-suite-100000072.htmlGenerate BiomedicinesGenerate:Biomedicines Fortifies Leadership in Generative AI with ...
Generate:Biomedicines Fortifies Leadership in Generative AI with Advancing Clinical Pipeline and Expanded Amgen Collaboration, Overviewed at the 42nd Annual ...
https://www.morningstar.com/news/business-wire/20240104730021/generatebiomedicines-fortifies-leadership-in-generative-ai-with-advancing-clinical-pipeline-and-expanded-amgen-collaboration-overviewed-at-the-42nd-annual-jp-morgan-healthcare-conference
Ver más (3)Inversores3
T. Rowe Price
Amgen
Fidelity Management and Research Company